Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
ACS Applied Materials & Interfaces
|
June 18, 2024
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2018
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sánchez-García, Naroa Serna, Patricia Álamo, et al.
International Journal of Molecular Sciences
|
May 14, 2022
An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials
Eloi Parladé, Eric Voltà-Durán, Olivia Cano-Garrido, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 14, 2020
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4<sup>+</sup> colorectal cancer stem cells
Naroa Serna, Patricia Álamo, Prashanthi Ramesh, et al.
Pharmaceutics
|
March 29, 2023
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, et al.
Pharmaceutics
|
March 26, 2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
Julieta María Sánchez, José Vicente Carratalá, Naroa Serna, et al.
Theranostics
|
May 7, 2020
Selective delivery of T22-PE24-H6 to CXCR4<sup>+</sup> diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
Aïda Falgàs, Victor Pallarès, Naroa Serna, et al.
Acta Biomaterialia
|
July 1, 2020
A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity
Laura Sánchez-García, Rita Sala, Naroa Serna, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 12, 2020
Artificial Inclusion Bodies for Clinical Development
Julieta M Sánchez, Hèctor López-Laguna, Patricia Álamo, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
March 8, 2016
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles
Naroa Serna, María Virtudes Céspedes, Paolo Saccardo, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
ACS Applied Materials & Interfaces
|
June 18, 2024
Hybrid Micro-/Nanoprotein Platform Provides Endocrine-like and Extracellular Matrix-like Cell Delivery of Growth Factors
Hèctor López-Laguna, Penelope M Tsimbouri, Vineetha Jayawarna, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
February 7, 2018
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sánchez-García, Naroa Serna, Patricia Álamo, et al.
International Journal of Molecular Sciences
|
May 14, 2022
An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials
Eloi Parladé, Eric Voltà-Durán, Olivia Cano-Garrido, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 14, 2020
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4<sup>+</sup> colorectal cancer stem cells
Naroa Serna, Patricia Álamo, Prashanthi Ramesh, et al.
Pharmaceutics
|
March 29, 2023
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, et al.
Pharmaceutics
|
March 26, 2022
The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
Julieta María Sánchez, José Vicente Carratalá, Naroa Serna, et al.
Theranostics
|
May 7, 2020
Selective delivery of T22-PE24-H6 to CXCR4<sup>+</sup> diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
Aïda Falgàs, Victor Pallarès, Naroa Serna, et al.
Acta Biomaterialia
|
July 1, 2020
A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity
Laura Sánchez-García, Rita Sala, Naroa Serna, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
February 12, 2020
Artificial Inclusion Bodies for Clinical Development
Julieta M Sánchez, Hèctor López-Laguna, Patricia Álamo, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
March 8, 2016
Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles
Naroa Serna, María Virtudes Céspedes, Paolo Saccardo, et al.
Page
of 6